Disposition of 1914 shares by Cyrus Harmon of Olema Pharmaceuticals at 8.08 subject to Rule 16b-3
| OLMA Stock | USD 8.52 0.12 1.43% |
About 54% of Olema Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding Olema Pharmaceuticals suggests that many traders are impartial. The current market sentiment, together with Olema Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Olema Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Olema Pharmaceuticals Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at thelincolnianonline.com
![]() |
Olema Pharmaceuticals Current Investor Sentiment
Comfort Level 46
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Olema Pharmaceuticals' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Olema Pharmaceuticals.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentDisposing |
Olema Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Olema Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Olema Pharmaceuticals Historical Investor Sentiment
Investor biases related to Olema Pharmaceuticals' public news can be used to forecast risks associated with an investment in Olema. The trend in average sentiment can be used to explain how an investor holding Olema can time the market purely based on public headlines and social activities around Olema Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Olema Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Olema Pharmaceuticals and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Olema Pharmaceuticals news discussions. The higher the estimate score, the more favorable the investor's outlook on Olema Pharmaceuticals.
Olema Pharmaceuticals Fundamental Analysis
We analyze Olema Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Olema Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Olema Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Olema Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Olema Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Olema Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Olema Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Olema Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Olema Pharmaceuticals Related Equities
| VSTM | Verastem | 21.03 | ||||
| GOSS | Gossamer Bio | 10.33 | ||||
| KALV | Kalvista Pharmaceuticals | 9.10 | ||||
| PRTA | Prothena Plc | 3.22 | ||||
| VTYX | Ventyx Biosciences | 2.70 | ||||
| CRVS | Corvus Pharmaceuticals | 1.60 | ||||
| FDMT | 4D Molecular | 1.48 | ||||
| ABSI | Absci Corp | 1.42 | ||||
| LXRX | Lexicon Pharmaceuticals | 2.01 | ||||
| RGNX | Regenxbio | 3.21 |
Complementary Tools for Olema Stock analysis
When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
